Grantham, Mayo, Van Otterloo & Co (GMO)’s Zimmer Biomet ZBH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-23,564
| Closed | -$2.64M | – | 595 |
|
2023
Q3 | $2.64M | Buy |
23,564
+9,096
| +63% | +$1.02M | 0.01% | 382 |
|
2023
Q2 | $2.11M | Sell |
14,468
-3,432
| -19% | -$500K | 0.01% | 436 |
|
2023
Q1 | $2.31M | Sell |
17,900
-17,800
| -50% | -$2.3M | 0.01% | 407 |
|
2022
Q4 | $4.55M | Buy |
+35,700
| New | +$4.55M | 0.02% | 352 |
|
2021
Q2 | – | Sell |
-4,436
| Closed | -$710K | – | 864 |
|
2021
Q1 | $710K | Buy |
+4,436
| New | +$710K | ﹤0.01% | 642 |
|
2017
Q4 | – | Sell |
-641,484
| Closed | -$75.1M | – | 618 |
|
2017
Q3 | $75.1M | Sell |
641,484
-39,450
| -6% | -$4.62M | 0.44% | 53 |
|
2017
Q2 | $87.4M | Buy |
680,934
+16,361
| +2% | +$2.1M | 0.48% | 52 |
|
2017
Q1 | $81.2M | Sell |
664,573
-17,606
| -3% | -$2.15M | 0.46% | 54 |
|
2016
Q4 | $70.4M | Buy |
682,179
+138,648
| +26% | +$14.3M | 0.38% | 68 |
|
2016
Q3 | $70.7M | Buy |
543,531
+6,900
| +1% | +$897K | 0.33% | 73 |
|
2016
Q2 | $64.6M | Buy |
536,631
+63,395
| +13% | +$7.63M | 0.27% | 85 |
|
2016
Q1 | $50.5M | Sell |
473,236
-111,979
| -19% | -$11.9M | 0.19% | 116 |
|
2015
Q4 | $60M | Sell |
585,215
-73,345
| -11% | -$7.52M | 0.22% | 89 |
|
2015
Q3 | $61.9M | Sell |
658,560
-208,493
| -24% | -$19.6M | 0.21% | 93 |
|
2015
Q2 | $94.7M | Sell |
867,053
-105,600
| -11% | -$11.5M | 0.31% | 71 |
|
2015
Q1 | $114M | Buy |
972,653
+5,837
| +0.6% | +$686K | 0.34% | 58 |
|
2014
Q4 | $110M | Sell |
966,816
-151,077
| -14% | -$17.1M | 0.3% | 63 |
|
2014
Q3 | $112M | Buy |
1,117,893
+63,199
| +6% | +$6.35M | 0.3% | 60 |
|
2014
Q2 | $110M | Sell |
1,054,694
-678,099
| -39% | -$70.4M | 0.3% | 61 |
|
2014
Q1 | $164M | Sell |
1,732,793
-555,124
| -24% | -$52.5M | 0.43% | 47 |
|
2013
Q4 | $213M | Sell |
2,287,917
-251,322
| -10% | -$23.4M | 0.52% | 38 |
|
2013
Q3 | $209M | Sell |
2,539,239
-755,851
| -23% | -$62.1M | 0.55% | 33 |
|
2013
Q2 | $247M | Buy |
+3,295,090
| New | +$247M | 0.64% | 34 |
|